Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
MethylGene Inc.
ClinicalTrials.gov Identifier:
NCT00679133
First received: May 14, 2008
Last updated: June 1, 2012
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)